Citi To Exit Mexican Consumer Banking Business

Citi said that it plans to exit the consumer, small business and middle market banking operations in Mexico as part of its strategic refresh.

Citi, which has operated in Mexico for more than a century, said that it will continue to operate a locally-licensed banking business in Mexico through its global Institutional Clients Group. Citi will continue to invest in and grow those institutional banking operations, along with its Private Banking franchise.

The Mexico consumer and small business banking operations included in the intended exit represent the entirety of the Latin America Global Consumer Banking unit. In the first three quarters of 2021, the businesses Citi intends to exit together accounted for about $3.5 billion in revenue, $1.2 billion in earnings before tax, Citi said in a statement.

Citigroup said in April 2021 that it would exit its consumer-banking operations in 13 countries across Asia and parts of Europe to focus more on wealth management outside the U.S.

The bank then stated that it would exit consumer operations in Australia, Bahrain, China, India, Indonesia, Korea, Malaysia, the Philippines, Poland, Russia, Taiwan, Thailand and Vietnam. Meanwhile, the bank said it would focus its Global Consumer Bank presence in Singapore, Hong Kong, the UAE and London.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT